0Y7T Allergan Plc

TIDMIRSH TIDM0Y7T 
 
 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

   1. KEY INFORMATION 
 
Name of person dealing (Note 1)         Millennium International Management LP 
Company dealt in                        Allergan plc 
Class of relevant security to which     IE00BY9D5467 
the dealings being disclosed relate 
(Note 2) 
Date of dealing                         11(th) May 2020 
 

2. INTERESTS AND SHORT POSITIONS

   1. Interests and short positions (following dealing) in the class ofrelevant 
      security dealt in(Note 3) 
 
                                             Long           Short 
                                             Number    (%)  Number    (%) 
(1) Relevant securities                      0              0 
                                              (0.000%)       (0.000%) 
(2) Derivatives (other than options)         -              - 
(3) Options and agreements to purchase/sell  -              - 
Total                                        0              0 
                                              (0.000%)       (0.000%) 
 
 

b. Interests and short positionsin relevant securitiesof the company, other than the class dealt in (Note 3)

 
Class of relevant security:                   Long           Short 
                                              Number    (%)  Number    (%) 
(1) Relevant securities 
 
 (2) Derivatives (other than options) 
 
 (3) Options and agreements to purchase/sell 
Total 
 
 

Ap20

3. DEALINGS (Note 4)

   1. Purchases and sales 
 
                                               Price per unit (Note 5) 
Purchase/sale   Number of relevant securities   (USD) 
Sale            130,165                        193.01 
Sale            965,039                        193.01 
Sale            415,101                        193.01 
Sale            276,702                        193.01 
Sale            645,796                        193.01 
Sale            5,979                          193.01 
Purchase        133                            193.01 
Purchase        14,619                         193.01 
Sale            1,688,153                      193.01 
Purchase        2,580                          193.01 
Sale            8                              193.01 
Purchase        3,721,191                      193.01 
Sale            3,826,467                      193.01 
Sale            1,270,619                      193.01 
 
   1. Exercising 
 
Product name,      Number of securities  Exercise price per unit (Note 5) 
 e.g. call option 
 
 

b. Other dealings (including transactions in respect of new securities) (Note 4)

 
Nature of transaction  Details  Price per unit 
 (Note 8)                        (if applicable) (Note 5) 
 
 
 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

 
 
 
 
 
 Is a Supplemental Form 8 attached? (Note 9) NO 
 
 
Date of disclosure                                            12(th) May 2020 
Contact name                                                  Milos Naumovic 
Telephone number                                              +44 203 650 8203 
If a connected EFM, name of offeree/offeror with which 
 connected 
If a connected EFM, state nature of connection (Note 10) 
 
 

View source version on businesswire.com: https://www.businesswire.com/news/home/20200512005523/en/

 
    CONTACT: 

Millennium Partners, L.P.

 
    SOURCE: Millennium Partners, L.P. 
Copyright Business Wire 2020 
 

(END) Dow Jones Newswires

May 12, 2020 10:15 ET (14:15 GMT)

Allergan (LSE:0Y7T)
Historical Stock Chart
From Mar 2024 to Apr 2024

Allergan (LSE:0Y7T)
Historical Stock Chart
From Apr 2023 to Apr 2024